Skip to main content

Dr. Dilan A. Patel, MD

Medical Oncology (Medical Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
12
In the NPI registry since
2014
Medicare patients seen, 2024
315

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2014Medical school: University of Tennessee, Hsc, College of Medicine
  • 2014Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    MO license 2020020085
  • Internal Medicine Physician
    MO license 2020020085

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
315
Services billed
30,302
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes10736
Established patient office or other outpatient visit, 30-39 minutes6651
Administration of chemotherapy into vein, 1 hour or less2616
Injection of drug or substance under skin or into muscle1917
New patient office or other outpatient visit, 45-59 minutes1818
Established patient office or other outpatient visit, 20-29 minutes1717
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1515

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 1 companies reported 1 payments worth $103 in total to this clinician.

By company
Adc Therapeutics America, Inc.$103
By type
Food and Beverage$103

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Missouri →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $337,169 in research payments for these studies, mostly to the institutions running them.

  • A phase 1B2 openlabel study of PF07901801 in combination with glofitamab after a fixed single dose of obinutuzumab in participants with relapsedrefractory diffuse large b cell lymphoma not eligible for stem cell trans…
    Pfizer Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Medical Oncology clinicians in Saint Louis

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 17, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1356757736. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.